PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER
- Conditions
- Respiratory Syncytial Virus Infection
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1100
- Registration Number
- NCT06546800
- Locations
- 🇯🇵
Pfizer, Tokyo, Japan
A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT06541678
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
- Conditions
- Pneumococcal Disease
- Interventions
- Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 300
- Registration Number
- NCT06531538
- Locations
- 🇺🇸
Bluegrass Clinical Research, Inc., Louisville, Kentucky, United States
🇺🇸Bio-Medical Research LLC, Miami, Florida, United States
🇺🇸Tekton Research, LLC., Beaumont, Texas, United States
A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.
- Conditions
- Migraine
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06532357
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT06532383
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 850
- Registration Number
- NCT06531109
- Locations
- 🇺🇸
C2 Research Center, Montgomery, Alabama, United States
🇺🇸Rao Dermatology, Fresno, California, United States
🇺🇸Southern California Clinical Research, Santa Ana, California, United States
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
- Conditions
- Pneumococcal Disease
- Interventions
- Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)Biological: 15-valent pneumococcal conjugate vaccine (PCV15)
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 800
- Registration Number
- NCT06524414
- Locations
- 🇵🇷
Caribbean Medical Research Center, San Juan, Puerto Rico
🇵🇷University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico
🇵🇷The Hispanic Alliance for Clinical and Translational Research, San Juan, Puerto Rico
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 52
- Registration Number
- NCT06507904
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2
- Registration Number
- NCT06504524
- Locations
- 🇩🇪
Pfizer, Berlin, Germany
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
- Conditions
- Breast CancerMalignant Neoplasm of Breast
- Interventions
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 5087
- Registration Number
- NCT06495164
- Locations
- 🇺🇸
Pfizer New York, New York, New York, United States